Skip to main content

Investigator-Initiated Studies

Through our Investigator-Initiated Studies program, UCB supports unsolicited and independently initiated and conducted studies that contribute to medical and scientific knowledge and drive advancements in patient care. 

Therapeutic Areas of Interest in Immunology and Neurology, Including Rare Diseases

Dermatology

  • Hidradenitis Suppurativa
  • Plaque Psoriasis

Epilepsy

  • Acute Seizure and Seizure Emergencies, including Seizure Clusters and Prolonged Seizures
  • Developmental and Epileptic Encephalopathies (DEEs)
  • Focal Onset Seizures
  • Rapid and Early Seizure Termination
  • Rare Epilepsies
  • Seizure Action Plans

Rare Disease

  • Generalized Myasthenia Gravis

Rheumatology

  • Ankylosing Spondylitis / Radiographic Axial Spondyloarthritis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus

As part of this program, UCB accepts unsolicited requests for funding and/or investigational drug supplies to support these studies. Should you have any questions, you may contact your local UCB Medical Science Liaison.

Submitting a Concept:

To submit a concept, please click the link below to access the eRequest Online Submission Portal. 

Submit an IIS Concept

All concepts submitted will be evaluated by a Review Committee. If a concept is recommended for a full proposal submission, an IIS Team member will contact the applicant with further instructions. 

For inquiries regarding the IIS process, please email IISmailbox@ucb.com.